Best TWAS P=7.45e-22 · Best GWAS P=3.24e-23 conditioned to 1
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Artery Aorta | B3GNT7 | 0.30 | 0.20 | lasso | 6 | 0.16 | 3.2e-09 | -9.9 | 9.6 | 9.3e-22 | -0.99 | 0.00 | 1.00 | FALSE |
2 | GTEx | Cells Transformed fibroblasts | EIF4E2 | 0.16 | 0.06 | lasso | 3 | 0.05 | 2.2e-04 | -5.6 | -5.7 | 1.5e-08 | 0.04 | 0.01 | 0.98 | FALSE |
3 | GTEx | Colon Transverse | EIF4E2 | 0.27 | 0.17 | enet | 19 | 0.18 | 7.7e-09 | -5.5 | 5.4 | 6.4e-08 | -0.06 | 0.01 | 0.99 | FALSE |
4 | GTEx | Colon Transverse | AC073254.1 | 0.22 | 0.13 | lasso | 4 | 0.15 | 9.3e-08 | -5.4 | 5.6 | 2.5e-08 | -0.04 | 0.01 | 0.99 | FALSE |
5 | GTEx | Heart Left Ventricle | EIF4E2 | 0.41 | 0.23 | lasso | 3 | 0.27 | 1.6e-14 | -5.6 | 5.4 | 5.3e-08 | -0.05 | 0.01 | 0.99 | FALSE |
6 | GTEx | Prostate | B3GNT7 | 0.34 | 0.15 | lasso | 3 | 0.08 | 4.4e-03 | -9.6 | 9.6 | 7.5e-22 | -0.99 | 0.01 | 0.98 | TRUE |
7 | GTEx | Testis | B3GNT7 | 0.31 | 0.06 | lasso | 7 | 0.09 | 5.8e-05 | -9.6 | 8.2 | 2.5e-16 | -0.81 | 0.01 | 0.98 | FALSE |
8 | ROSMAP | Brain Pre-frontal Cortex | EIF4E2 | 0.12 | 0.07 | lasso | 6 | 0.06 | 9.4e-08 | -5.4 | -5.4 | 6.7e-08 | 0.04 | 0.01 | 0.98 | FALSE |
9 | The Cancer Genome Atlas | Breast Invasive Carcinoma | EIF4E2 | 0.03 | 0.03 | enet | 8 | 0.04 | 4.4e-08 | 4.1 | -5.9 | 3.6e-09 | 0.07 | 0.22 | 0.77 | FALSE |
10 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | B3GNT7 | 0.03 | 0.01 | blup | 36 | 0.02 | 4.0e-03 | -8.8 | 8.5 | 1.8e-17 | -0.91 | 0.01 | 0.95 | FALSE |
11 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | EFHD1 | 0.11 | 0.01 | blup | 70 | 0.03 | 1.0e-02 | 3.3 | 5.5 | 5.0e-08 | 0.00 | 0.05 | 0.04 | TRUE |
12 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | EIF4E2 | 0.12 | 0.12 | lasso | 10 | 0.11 | 4.8e-07 | -5.6 | 5.3 | 1.2e-07 | -0.04 | 0.01 | 0.99 | FALSE |
13 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | TIGD1 | 0.09 | 0.07 | blup | 57 | 0.07 | 5.6e-05 | -5.5 | 5.4 | 5.4e-08 | -0.07 | 0.01 | 0.98 | FALSE |
14 | The Cancer Genome Atlas | Brain Lower Grade Glioma | B3GNT7 | 0.03 | 0.03 | blup | 33 | 0.02 | 8.8e-04 | 4.9 | -5.7 | 1.5e-08 | 0.57 | 0.17 | 0.32 | FALSE |
15 | The Cancer Genome Atlas | Brain Lower Grade Glioma | EFHD1 | 0.05 | 0.01 | blup | 70 | 0.01 | 1.7e-02 | -3.1 | -5.9 | 3.3e-09 | -0.03 | 0.04 | 0.34 | TRUE |
16 | The Cancer Genome Atlas | Brain Lower Grade Glioma | EIF4E2 | 0.03 | 0.01 | blup | 60 | 0.02 | 2.7e-03 | 3.1 | -5.6 | 1.7e-08 | 0.05 | 0.09 | 0.14 | FALSE |
17 | The Cancer Genome Atlas | Prostate Adenocarcinoma | B3GNT7 | 0.05 | 0.06 | blup | 36 | 0.05 | 2.6e-06 | -9.6 | 9.0 | 1.9e-19 | -0.95 | 0.01 | 0.99 | FALSE |
18 | The Cancer Genome Atlas | Thyroid Carcinoma | EIF4E2 | 0.03 | 0.01 | blup | 63 | 0.02 | 4.7e-03 | 4.1 | -5.2 | 2.0e-07 | 0.06 | 0.08 | 0.11 | FALSE |